Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion type Assertion NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_head.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion wasGeneratedBy ECO_0000203 NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion wasDerivedFrom befree-2016 NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion SIO_000772 17761709 NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion evidence source_evidence_literature NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.